Skip to main content
. Author manuscript; available in PMC: 2017 Jan 17.
Published in final edited form as: Int J Cancer. 2015 Feb 5;137(3):625–637. doi: 10.1002/ijc.29427

Table 2.

Age-and multivariable adjusted hazard ratios and 95% confidence intervals for endometrial cancer by life-course body fatness among NHS (1988-2010) and NHS II (1989-2009) participants

No. cases/person-years Age-adjusted HR Multivariate-adjusted HR3 (95% CI) Multivariate adjusted HR3 + Menstrual cycle characteristics4 (95% CI) Multivariate adjusted HR3 + recent BMI5,6 (95% CI)
Body fatness1 at age 5, Level
1 264 / 731,584 1.00 1.00 1.00 1.00
2 193 / 731,679 1.10 1.10 (0.91-1.33) 1.09 (0.90-1.32) 1.09 (0.90-1.32)
3 136 / 553,864 1.02 1.02 (0.83-1.26) 1.00 (0.81-1.23) 0.91 (0.73-1.11)
4 95 / 304,037 1.21 1.19 (0.94-1.51) 1.16 (0.91-1.47) 0.95 (0.74-1.21)
5+ 69 / 176,878 1.30 1.27 (0.97-1.66) 1.23 (0.94-1.61) 0.92 (0.70-1.21)
P trend 0.05 0.08 0.15 0.30
Body fatness1 at age 10, Level
1 190 / 554,482 1.00 1.00 1.00 1.00
2 196 / 736,442 1.07 1.09 (0.89-1.33) 1.07 (0.87-1.31) 1.04 (0.85-1.27)
3 147 / 532,689 1.17 1.18 (0.95-1.47) 1.14 (0.92-1.42) 1.00 (0.80-1.25)
4 100 / 374,512 1.12 1.10 (0.86-1.41) 1.06 (0.83-1.36) 0.83 (0.64-1.06)
5+ 124 / 299,917 1.58 1.54 (1.22-1.94) 1.47 (1.17-1.86) 1.05 (0.82-1.33)
P trend <0.001 0.001 0.01 0.65
Body fatness1 at age 20, Level
1,2 270 / 839,815 1.00 1.00 1.00 1.00
3 222 / 915,989 0.95 0.95 (0.79-1.13) 0.93 (0.77-1.11) 0.82 (0.68-0.98)
4 158 / 492,248 1.31 1.29 (1.05-1.57) 1.24 (1.02-1.52) 0.94 (0.77-1.16)
5+ 107 / 249,990 1.75 1.65 (1.31-2.07) 1.61 (1.28-2.02) 0.93 (0.73-1.20)
P trend <0.001 <0.001 <0.001 0.62
Average childhood body fatness (ages 5 – 10)2, Level
1-2 381 / 1,263,067 1.00 1.00 1.00 1.00
2.5-3 168 / 589,824 1.17 1.17 (0.97-1.41) 1.14 (0.95-1.37) 1.03 (0.85-1.24)
3.5-4.5 138 / 483,640 1.17 1.14 (0.94-1.39) 1.11 (0.91-1.35) 0.89 (0.72-1.08)
5+ 70 / 161,512 1.47 1.43 (1.11-1.85) 1.39 (1.07-1.80) 0.97 (0.75-1.27)
P trend 0.003 0.01 0.02 0.44
Average adolescent body fatness (ages 10 – 20)2, Level
1-2 261 / 816,097 1.00 1.00 1.00 1.00
2.5-3 208 / 831,429 1.03 1.03 (0.86-1.24) 1.01 (0.84-1.21) 0.92 (0.76-1.11)
3.5-4.5 211 / 697,746 1.28 1.27 (1.05-1.52) 1.22 (1.01-1.47) 0.93 (0.77-1.13)
5+ 77 / 152,771 1.92 1.83 (1.41-2.37) 1.76 (1.35-2.28) 1.03 (0.78-1.36)
P trend <0.001 <0.001 <0.001 0.81
BMI at age 18, kg/m2
≤ 19.9 216 / 931,989 1.00 1.00 1.00 1.00
20.0-21.4 181 / 646,539 1.07 1.10 (0.90-1.34) 1.08 (0.88-1.31) 0.94 (0.77-1.15)
21.5-22.9 135 / 405,503 1.17 1.19 (0.95-1.48) 1.15 (0.93-1.44) 0.89 (0.71-1.11)
≥23.0 225 / 514,012 1.70 1.64 (1.35-1.99) 1.58 (1.30-1.92) 0.91 (0.74-1.13)
<0.001 <0.001 <0.001 0.34
Recent BMI, kg/m2
≤ 24.9 242 / 1,323,670 1.00 1.00 1.00 N/A7
25.0-29.9 202 / 679,660 1.22 1.23 (1.01-1.49) 1.22 (1.00-1.47)
30.0-34.9 150 / 295,189 2.14 2.12 (1.71-2.63) 2.08 (1.68-2.58)
≥35.0 163 / 199,524 4.34 4.13 (3.29-5.16) 4.05 (3.24-5.07)
<0.001 <0.001 <0.001
Weight change since age 18, kg
Loss (≤ − 2) 32 / 196,640 0.76 0.76 (0.48-1.21) 0.76 (0.48-1.21) 0.60 (0.37-0.95)
Stable (−2 to + 2) 41 / 225,427 1.00 1.00 1.00 1.00
Gain (+ 2 – < 5) 55 / 305761 1.11 1.10 (0.73-1.65) 1.10 (0.73-1.65) 1.15 (0.76-1.73)
    (+ 5 – < 10) 104 / 482,117 1.16 1.16 (0.81-1.66) 1.16 (0.81-1.67) 1.26 (0.87-1.81)
    (+ 10 – < 15) 98 / 404,216 1.13 1.11 (0.77-1.60) 1.11 (0.77-1.60) 1.22 (0.85-1.77)
    (+ 15 – < 20) 100 / 290,139 1.45 1.40 (0.97-2.02) 1.40 (0.97-2.02) 1.54 (1.07-2.23)
    (+20 – < 25) 75 / 207,044 1.48 1.43 (0.97-2.10) 1.42 (0.96-2.09) 1.57 (1.06-2.31)
    (≥ + 25) 252 / 386,699 2.83 2.54 (1.80-3.59) 2.52 (1.78-3.55) 2.71 (1.92-3.82)
P trend <0.001 <0.001 <0.001 <0.001
1

Participants were asked to recall their body fatness at ages 5, 10, and 20, using a nine-level drawing (Figure 1), where Level 1 corresponds to the leanest and Level 9 the most overweight.

2

Average childhood and adolescent body fatness were the average of the levels at ages 5 and 10, and ages 10 and 20 respectively.

3

Adjusted for smoking history [never, past, current], oral contraceptive use [never, <3 years, 3-5 years, > 5years], postmenopausal hormone use [premenopausal (reference), post-menopausal – never; postmenopausal – past; post-menopausal current – estrogen only; postmenopausal current – estrogen & progesterone / other], age at menopause [premenopausal/unknown, < 45 years, 45-< 47 years, 47 - <49 years, 49- <51 years, 51- <53 years, 53+ years], family history of colon/rectal cancer, family history of endometrial cancer, height (inches; continuous), parity and age at last birth[1-2 & <30 yrs, 1-2 & ≥ 30 yrs, 3-4 & < 30 yrs, 3-4 & ≥ 30 yrs, ≥ 5 children], physical activity [adolescent & age 20 models: <21, 21-<36, 36-<53, 54-<81, 81+ METS/week; weight change /recent BMI model: <3, 3-<9, 9-<18, 18-<27, 27+ METS/week]

4

Menstrual cycle characteristics: age of menarche [≤11, 12, 13, ≥14 years], menstrual cycle regularity at age 18 [regular, irregular/no periods]

5

BMI: body mass index

6

Weight change model adjusted for weight at age 18, not recent BMI

7

Recent BMI models not adjusted for recent BMI